Among the 208 DEGs and ten hub genes identified, CDK1 and CDC45 were associated with unfavorable HNSCC prognosis, and three potential small molecule drugs for treating HNSCC were identified. This evidence concerns the gene CDC45 and head and neck squamous cell carcinoma.